EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSODEG00000007904
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSODEG00000002105
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSODEG00000000729
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSODEG00000009349
Gene Symbol: PSMA1
2 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSODEG00000014244
Gene Symbol: PSMA3
2 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSODEG00000005003
Gene Symbol: PSMA5
2 Cross references
207 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSODEG00000004073
Gene Symbol: PSMA7
3 Cross references
151 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSODEG00000018364
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSODEG00000000390
Gene Symbol: PSMB1
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSODEG00000015334
Gene Symbol: PSMB10
3 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSODEG00000006435
Gene Symbol: PSMB2
3 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSODEG00000017437
Gene Symbol: PSMB3
2 Cross references
257 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).